Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Baseline disease modifying therapies (DMTs)----1件: 13
2BG00012 (DMF)----1件: 13
3BG00012 (DMF) (Tecfidera®.)----1件: 13
4Biologic DMARD----2件: 46, 271
5Biologic DMARDs----1件: 107
6Biological DMARDs----2件: 86, 107
7Classic DMARDs treatment group----1件: 46
8Co-medication: Synthetic DMARDs----1件: 46
9Combination of DMARDs----1件: 107
10Conventional DMARD combination----1件: 46
11Conventional DMARDs----1件: 46
12Conventional Synthetic DMARD----1件: 46
13CP-690-550-10 (DMID D1600180)----1件: 107
14Daunorubicin
(Synonym: DM)		1件: Daunorubicin1件: D07776 (Name: DM)2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 65
15Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg)2件: Dextromethorphan (Synonym: NightTime Cough DM Maximum Strength),
Quinidine		2件: D03742 ,
D08458 		11件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A,
SIGMAR1 💬		22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬1件: 8
16Dimethyl Fumarate (DMF)1件: Dimethyl fumarate1件: D03846 1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬3件: 13, 51, 86
17Dimethyl fumarate [DMF]1件: Dimethyl fumarate1件: D03846 1件: KEAP1 💬6件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬1件: 13
18Dimethyl sulfoxide (DMSO)1件: Dimethyl sulfoxide (Synonym: DMSO)1件: D01043 --1件: 226
19Disease modifying treatment (DMT)----1件: 13
20Disease-modifying antirheumatic drugs (DMARDs)----1件: 46
21DM----2件: 6, 8
22DM-1992----1件: 6
23DMARD----1件: 46
24DMARD cessation----1件: 46
25DMARD maintenance----1件: 46
26DMARD Therapy----1件: 46
27DMARDS----2件: 46, 271
28DMARDs (disease-modifying antirheumatic drugs)----1件: 46
29DMARDs (methotrexate1件: Methotrexate1件: D00142 2件: DHFR,
DHFR2 💬		5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬1件: 46
30DMARDs or Biologics----1件: 46
31DMPS1件: 2,3-Dimercapto-1-propanesulfonic acid (Synonym: DMPS)---1件: 171
32DMSA1件: Succimer (Synonym: DMS-A)1件: D00572 --1件: 171
33DMSO1件: Dimethyl sulfoxide (Synonym: DMSO)1件: D01043 --1件: 226
34DMSO cocktail1件: Dimethyl sulfoxide (Synonym: DMSO)1件: D01043 --1件: 226
35DMT----1件: 13
36DMT continuation----1件: 13
37DMX-200----1件: 222
38Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc1件: Etanercept1件: D00742 2件: LTA,
TNF 💬		67件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46
39Exposure to one or more disease-modifying drug(s)(DMDs) used to treat MS----1件: 13
40First line DMT----1件: 13
41HUC-MSC + DMARDs----1件: 46
42Injectable MS DMT----1件: 13
43IONIS-DMPKRx----1件: 113
44Non-biologic Disease Modifying Anti-Rheumatic Drug (DMARD)----1件: 46
45Non-Biologic DMARDs----3件: 46, 86, 107
46Non-biological DMARDs----1件: 46
47Nonbiologic DMARDs of investigator's choice----1件: 46
48Patient treated with DMARD----1件: 46
49Permitted DMARDs----1件: 46
50Phase 1: Conventiaonal DMARD----1件: 46
51Rheumatoid Arthritis With Disease-Modifying Drugs (DMARDs)----1件: 46
52Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)----1件: 46
53Standard MS DMT----1件: 13
54Standard MS DMTs----1件: 13
55Synthetic DMARD(s)----1件: 46
56Targeted synthetic DMARD class----1件: 46
57Therapy with disease-modifying anti rheumatic drugs (DMARD)----1件: 46
58TNF-a antagonists, non-TNFs, DMARD non-biologics----2件: 46, 271
59Trivalent chromium versus synthetic and/ or biological DMARDs1件: Chromium---1件: 46
60UC-MSC+DMARDS----1件: 46
61Vinblastine, vincristine, prednisone, daunorubicin
(Synonym: DM)		4件: Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		4件: D00473 ,
D07776 (Name: DM),
D08675 ,
D08679 		12件: NR3C1,
TOP2A,
TOP2B,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬		12件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Platinum drug resistance, Prion disease, Salmonella infection 💬1件: 65